1. Home
  2. VFF vs TLSA Comparison

VFF vs TLSA Comparison

Compare VFF & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$2.88

Market Cap

396.2M

Sector

N/A

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.21

Market Cap

166.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
TLSA
Founded
1989
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.2M
166.7M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
VFF
TLSA
Price
$2.88
$1.21
Analyst Decision
Buy
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
997.3K
93.4K
Earning Date
06-17-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
184.38
N/A
EPS
0.27
N/A
Revenue
$215,937,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.98
N/A
P/E Ratio
$11.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.73
52 Week High
$4.99
$2.60

Technical Indicators

Market Signals
Indicator
VFF
TLSA
Relative Strength Index (RSI) 35.41 34.50
Support Level $2.85 N/A
Resistance Level $3.40 $1.56
Average True Range (ATR) 0.18 0.10
MACD -0.04 -0.01
Stochastic Oscillator 0.62 4.05

Price Performance

Historical Comparison
VFF
TLSA

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: